Clinical Research Directory

Inclusion Criteria: * Clinically significant symptoms of anxiety or depression based on self-report and clinical interview * Score on the MMSE-NR above 26 and competent to give informed consent as evaluated by a structural clinical assessment * Stable use of psychotropic medication for the last month. Periodic use of z-hypnotics is not exclusion criteria but will be restricted to a limited and pre-planned dosage per week. Stabilization of psychotropic medication can be offered to eligible patients before participation. * Prepared to share their challenges and work on maladaptive emotion regulation strategies in a group setting. * Able to attend most sessions. Exclusion Criteria: * Conditions requiring specialized treatment such as active psychosis and/or mania, untreated or unstable bipolar disorder, psychosis spectrum disorders or severe depressive episode * Acutely increased risk of suicide or deliberate self-harm * Dementia or amnestic mild cognitive impairment * Substance abuse including psychoactive drugs * Habitual use of prescribed anxiolytics or opiods. Help with gradual reduction and elimination before inclusion in treatment will be offered to potential participants * Uncorrected hearing loss * Symptoms of personality disorders that hinder participation in the group * Simultaneously participating in other psychotherapy * Living with ongoing highly social burden where greater flexibility in treatment is needed